Over many years, Kaken has been marketing a number of its original products under license or distributorship in overseas countries. Such out-licensed products include Mentax, Empynase, Sonifilan, and Fiblast.
Mentax is an antifungal agent launched or approved in Asian countries and the U.S.A.
Clenafin/Jublia is a topical agent for onychomycosis,launched in Japan,Canada,and the U.S.A.
Fiblast is a spray formulation to treat skin ulcers such as bed-sore and burns. After obtaining marketing authorization, Daewoong distribute Fiblast in Korea.
|Schering-Plough HealthCare Products||Launched||Lotrimin Ultra(OTC)|